Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study
2023 · The Lancet Regional Health - Europe · 179 citations
https://doi.org/10.1016/j.lanepe.2023.100747
S
Sudhir Venkatesan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
82
Papers
1.8K
Citations
17
h-index
19
i10-index
Sudhir Venkatesan is an academic researcher from AstraZeneca (United Kingdom). The author has contributed to research in topics: Influenza Virus Research Studies & Respiratory viral infections research & COVID-19 Clinical Research Studies. The author has an h-index of 17, co-authored 70 publications.
ORCID: 0000-0002-2093-5781Papers by this author
worksImpact of neuraminidase inhibitors on influenza A(H1N1)pdm09‐related pneumonia: an individual participant data meta‐analysis
2015 · Influenza and Other Respiratory Viruses · 73 citations
https://doi.org/10.1111/irv.12363
Missed opportunities for brief intervention in tobacco control in primary care: patients’ perspectives from primary health care settings in India
2015 · BMC Health Services Research · 18 citations
https://doi.org/10.1186/s12913-015-0714-6
Prediction of COVID-19 hospitalisation, ICU admission or death following ChAdOx1 vaccination using artificial intelligence: A clinical predictive model from the English RAVEN study
2026 · PLoS ONE · 0 citations
https://doi.org/10.1371/journal.pone.0336449
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat